medigraphic.com
ISSN 0210-5187 (Electronic)

2017, Number 2

<< Back Next >>

Med Cutan Iber Lat Am 2017; 45 (2)

Cutaneous leishmaniasis with good response to treatment with itraconazole

Castaño MB, Consigli J, López GVR, Pereyra S

Language: Spanish
References: 9
Page: 134-136
PDF size: 272.01 Kb.


ABSTRACT

Leishmaniasis is a parasitic disease caused by a flagellate intracellular protozoan of the genus Leishmania, and is transmitted to human by the bite of the female sandfly of the genus Lutzomyia. The clinical manifestations are varied and are related to the species of Leishmania infecting, the environment and the host immune response. We present the case of a male immunocompetent patient with cutaneous leishmaniasis who failed to respond to amphotericin B and cured with itraconazole showing good tolerance and no adverse effects.


REFERENCES

  1. Nógalo A, Molina SG, Norry GA, Romano S, Lorenz AM. Leishmaniasis cutánea primaria. Dermatol Argent. 2012; 18 (3): 228-230.

  2. Grimaldi G Jr, Tesh RB. Leishmaniases of the new world: current concepts and implications for future research. Clin Microbiol Rev. 1993; 6 (3): 230-250.

  3. Consigli J, Danielo C, Gallerano V, Papa M, Guidi A. Cutaneous leishmaniasis: successful treatment with itraconazole. Int J Dermatol. 2006; 45: 46-49.

  4. Baroni A, Aiello FS, Vozza A, Vozza G, Faccenda F, Brasiello M et al. Cutaneous leishmaniasis treated with itraconazole. Dermatol Ther. 2009; 22 (Suppl 1): 27-29.

  5. Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis. 2007; 5 (3): 150-158.

  6. López CL, Palacio BM, Cardona AJ. Eficacia de los azoles en el tratamiento de la leishmaniasis cutánea. Archivos de Medicina [en línea]. 2016; 12: 2-4. Disponible en: http://www.archivosdemedicina.com/medicina-de-familia/eficacia-de-los-azoles-en-el-tratamientode-la-leishmaniasis-cutanea.php?aid=9043.

  7. Amato VS, Padilha AR, Nicodemo AC, Duarte MI, Valentini M, Uip DE et al. Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study. Int J Infect Dis. 2000; 4: 153-157.

  8. Jacob R, Konnikov N. Antimicóticos por vía oral. En: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Dermatología en medicina general. Ed. Panamericana, Buenos Aires. 2012, pp. 2796-2806.

  9. Davis AJ, Kedzierski L. Recent advances in antileishmanial drug development. Curr Opin Investig Drugs. 2005; 6 (2): 163-169.




2020     |     www.medigraphic.com